Wellbutrin
Hypoactive Sexual Desire Disorder
University of Illinois at ChicagoPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Hypoactive Sexual Desire Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
TESTOSTERONE UNDECYLATE BioSante Pharmaceuticals | Phase 3 | B |
Calcium University of Illinois at Chicago | Phase 1/2 | CC |
VITAMIN D University of Illinois at Chicago | Phase 1/2 | CC |
Letrozole University of Illinois at Chicago | Phase 1/2 | CC |
Arimidex University of Illinois at Chicago | Phase 1/2 | CC |
VENLOR University of Illinois at Chicago | Phase 1/2 | CC |
Same molecule, other indications
Wellbutrin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →